Introduction
============

The split-dose regimen has demonstrated its superiority [@JR1599-1] [@JR1599-2] over the day-before regimen in determining a better colon cleansing and, therefore, for the detection of clinically relevant neoplasia [@JR1599-3] [@JR1599-4] . For these reasons, it is now considered by international guidelines to be the standard for bowel preparation for colonoscopies, along with the same-day regimen for afternoon colonoscopies [@JR1599-5] [@JR1599-6] . However, its application is suboptimal [@JR1599-7] , and this may account for the suboptimal rates of adequate cleansing achieved by some centers, compared with the standards required by ESGE and ASGE [@JR1599-8] [@JR1599-9] .

Barriers precluding the prescription of a split-dose regimen have been explored in a few studies [@JR1599-10] [@JR1599-11] , mainly in the setting of auditing of current practice. Conversely, corrective measures aiming at changing the practice have been prospectively tested in very few, small and selected cohorts [@JR1599-12] [@JR1599-13] [@JR1599-14] , and rarely with split-dose regimen adoption as the principal outcome [@JR1599-12] .

One scientific method involved in continuous quality improvement is the Plan-Do-Study-Act approach (PDSA) [@BR1599-15] [@JR1599-16] . This approach is characterized by cycles in which an initial analysis of a problem and of desired ameliorations determines observation-driven corrections which are verified through intermediate field tests and thereafter audited, to reinforce positive changes and discard ineffective ones [@JR1599-17] . The philosophy behind this method is that quality improvement can be effectively achieved only when it can be described as a process in which ameliorations are linked to indicators that can be measured. PDSA has already demonstrated its utility in optimizing bowel cleansing [@JR1599-13] [@JR1599-14] [@JR1599-18] , but without specifically addressing an increase in split-dose regimen adoption, and mainly in very selected cohorts.

The aim of this study was to use the PDSA approach to improve split-dose regimen adoption among several Italian endoscopic facilities, and to use the collected data to analyze factors favoring and limiting this adoption.

Methods
=======

A multicentre prospective study on consecutive colonoscopies executed in two different time frames was performed in 74 endoscopic centers in Central Italy selected by regional boards of the Italian national endoscopy society. Data were collected through an electronic form and were stored and managed by independent data managers.

The study was approved by the ethics committee of Sant'Andrea Hospital -- Sapienza University of Rome (protocol n. 10791/2013, approved 09/16/2013). An informed consent was obtained for every participant. The study has been registered in ClinicalTrials.gov (Identifier: NCT03581175).

Following the PDSA approach, the study was divided into three phases: Cycle 1, one educational phase, and Cycle 2.

Cycle 1
-------

During this part of the study, between September 2013 and February 2014, no variation was made to routine practice in regimen choice and communication or in the organization of the service, and colonoscopy practice was analyzed, with particular interest for bowel cleansing prescription, its adoption, and its outcomes.

After a literature review, a questionnaire was structured through expert agreement of the coordinating committee. Before colonoscopy, a trained investigator filled in the questionnaire for every outpatient or inpatient undergoing the exam. No exam was a priori excluded, provided that a complete colonoscopy with full bowel cleansing was planned, regardless of the product or regimen used. Therefore, the only exclusion criteria were: 1) the inability of the patients to comprehend the study and to agree with their inclusion; 2) the endoscopic examination being planned without a complete bowel cleansing (e. g. sigmoidoscopy prepared by enema). No patient comorbidity determined exclusion from the study if a full bowel cleansing regimen was prescribed and at least initiated.

The split-dose regimen was defined as a regimen in which one fraction of the product was consumed the day before the exam and the other one on the examination day, while in day-before and in same-day regimens, the whole product was consumed, respectively, on the day before or on the same day as the examination.

Demographic, clinical, and procedural variables were systematically registered through an anonymous electronic case report form (for the complete list of variables explored, see **Supplementary Material** , Statement 1).

Preparation-to-colonoscopy time was calculated as the interval between the self-reported last dose of preparation consumed and the effective colonoscopy initiation time. The planned (and not the effective) initiation time was conversely used in analyses evaluating the role of preprocedural variables in predicting split-dose regimen adoption.

Educational phase
-----------------

After all centers had concluded Cycle 1, independent data managers analyzed the collected data and provided each center with local and general statistics. Thereafter, meetings at a regional level were organized every 3 months to: discuss the collected data; query data to identify hypothetical barriers limiting the adoption of the split-dose regimen; review available evidence on the efficacy and tolerability of the split-dose regimen; discuss possible areas of intervention. After each center had attended one regional meeting, in September 2014, local facilities received a DVD containing a motivational letter, educational material (including digital presentation material), an implementation manual (including compulsory local checkpoints with regard to diffusion of educational material and internal meetings), freely customizable module samples and indications for self-reporting of local ameliorations (see [Table 1](#TB1599-1){ref-type="table"} ). No central coordination of corrective measures was undertaken, but each endoscopic unit was free to make any desired adjustment, in light of the interim analysis and ongoing auditing and discussion, according to a Plan-Do-Study-Act approach (see **Supplementary Fig. 1** ). Cycle 2 was initiated only after every center had completed local mandatory checkpoints and attended at least one additional regional meeting. No specific intervention was assigned to individual study participants in either cycle, and who were managed according to current practice.

###### Improvement process, PDSA-derived barriers and self-reported local interventions.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Aim** : Implementation of split-dose regimen adoption                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  **Tools** (DVD): Local and regional statisticsMotivational letter from study coordinatorsImplementation manualRecommendations from guidelinesReference list of published evidenceIdentified problems (during Cycle 1 and earlier regional meetings)Discussed areas of interventionPre-ordinated compulsory checkpointsIndications on self-reporting of ameliorationsDigital presentation materialChecklists to screen for patients requiring special considerationSamples of customizable modules for patients                                                                               

  **Identified problem (P)/Area of intervention**                                                                                                                                                                                                                                                                                                                                                                                                                                                                  **Improvement checkpoints (C)**\                                            **Self-reported ameliorations (A)**
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   **(date of execution/completion required)**                                 

  P1. Staff training                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               C1. Diffusion of educational material\                                      A1. Dissemination of guidelines and discussion of published evidence with regard to efficacy, safety, and tolerability of split-dose regimens
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   C2. Staff examination of educational material\                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   C3. Educational meeting with endoscopy staff\                               
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   C4. Educational letter to hospital wards                                    

  P2. Patient education                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            None                                                                        A2. Revision of written instructions, explicitly mentioning split-dose regimens, their efficacy, their tolerability, and the absence of significant increase in adverse events (especially while reaching the hospital)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               A3. Modules with customizable time for the consumption of the second dose of preparation\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               A4. Differentiation of preparation regimens according to colonoscopy time (including modification of split-dose regimens with a 75 %/25 % split delivery)\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               A5. Dedicated staff "navigating" the patients through comprehension of their regimen

  P3. Information provided by independent reservation systems                                                                                                                                                                                                                                                                                                                                                                                                                                                      C5. Educational meeting with staff of the independent reservation system\   A6. Implementation of endoscopy-coordinated prescription of bowel cleansing\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   C6. Diffusion of checklists                                                 A7.Diffusion of checklists to select patients needing to be "navigated" by endoscopy staff\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               A8. Diffusion of checklists to select patients to allocate to late-morning or afternoon colonoscopies

  P4. Colonoscopy scheduling                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       None                                                                        A9. Rescheduling of colonoscopies avoiding early-morning slots

  P5. Involvement of the anesthesiologist                                                                                                                                                                                                                                                                                                                                                                                                                                                                          None                                                                        A10. Discussion of anesthesiological guidelines and evidence on residual gastric volume after split-dose regimens\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               A11. Increased awareness in the use of deep sedation, with limited access
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PDSA, Plan-Do-Study-Act approach.

Cycle 2
-------

Between December 2015 and February 2016, colonoscopy practice was again monitored through the same initial questionnaire, looking for improvements.

Sample size
-----------

Due to the absence of epidemiological data on split-dose regimen adoption in Italy when the study was conceived, no formal sample size calculation was planned, but since a generalizable result was targeted, we decided to include more than 70 centers and at least 3500 patients per cycle, corresponding overall to a minimum of 7000 patients (i. e. 100 per center).

Enrolment in Cycle 1 and Cycle 2 closed after reaching the minimum number of required patients, which was checked on a weekly basis.

Statistical analysis
--------------------

The primary outcome of this study was the change in split-dose regimen adoption rate before (Cycle 1) and after (Cycle 2) the observation-driven implementation phase (PDSA). The secondary outcome was to analyze several patient-, center-, and procedure-related variables looking for differences between Cycle 1 and Cycle 2, and searching for any predicting values on different outcomes in multivariate models, the principle of which analyzed the adoption of split-dose versus day-before modality as the dependent variable; for this model, we a priori decided to consider only morning colonoscopies, since this is the setting for which the split-dose procedure is recommended, the setting in which its use is more challenging, and because a number of centers included did not perform afternoon colonoscopies. Other models reported as supplemental material considered the following dependent variables: the adoption of a regimen other than the day-before for afternoon colonoscopies; patients' willingness to repeat the preparation; endoscopist satisfaction; cleansing adequacy in the left and right colon.

Continuous variables were reported as means (and standard deviations) while categorical variables were reported as frequencies (proportions). Some continuous variables were categorized (see **Supplementary Material** : Statement 2).

Variables were reported separately for Cycle 1 and 2, and were compared using a Student's *t* test for continuous variables and a chi-squared test for categorical variables.

For each multivariate logistic regression model, a stepwise selection of independent variables was made using a *P* -to-enter \< 0.05, and a *P* -to-stay \< 0.1. The results are reported as odds ratios (OR), 95 % confidence intervals (CI), and *P* values.

A *P* value of \< 0.05 was considered to be statistically significant.

Results
=======

In total, 8267 patients were enrolled between February 2013 and February 2016 in 74 endoscopic centers in Central Italy (93.2 % public vs 6.8 % private facilities; 23 % academic institutions). The uploading process through the electronic system was completed for 8213 patients (99.3 %) who were finally considered for the study. Data on cleansing regimen were available for 100 % of patients included, since the lack of this variable was considered to be an incomplete upload, and the patient consequently excluded.

Characteristics of patients
---------------------------

Among the patients included, mean age was 60.3 (13.6) years, 54 % were male and 88.4 % were outpatients. In total, 4189 patients were enrolled in Cycle 1, while 4024 were enrolled in Cycle 2. Characteristics of patients included in the two cycles are presented and compared in [Table 2](#TB1599-2){ref-type="table"} .

###### Characteristics of patients included in Cycle 1 and Cycle 2.

  Variable                                                                                   Cycle 1 (n = 4189)   Cycle 2 (n = 4024)   *P* value
  ------------------------------------------------------------------------------------------ -------------------- -------------------- ------------------------------------------------
  Males, n (%)                                                                               2226 (53.1 %)        2206 (54.8 %)        0.1263
  Mean age (SD), years                                                                       60.38 (13.66)        60.20 (13.51)        0.5407
  Education, n (%)                                                                                                                     0.2031
  Primary                                                                                    868 (20.7 %)         797 (19.8 %)         
  Secondary I                                                                                1144 (27.3 %)        1104 (27.4 %)        
  Secondary II                                                                               1531 (36.5 %)        1437 (35.7 %)        
  Degree or above                                                                            646 (15.4 %)         686 (17.0 %)         
  Type of patient, n (%)                                                                                                               0.1225
  Outpatients                                                                                3680 (87.8 %)        3579 (88.9 %)        
  Inpatients                                                                                 509 (12.2 %)         445 (11.1 %)         
  Time to reach the hospital (outpatients only), n (%) [1](#FN1599-1){ref-type="table-fn"}                                             0.8383
   \< 1 h                                                                                    3222 (87.6 %)        3140 (87.7 %)        
  1 -- 2 h                                                                                   416 (11.3 %)         394 (11.0 %)         
   \> 2 h                                                                                    42 (1.1 %)           45 (1.3 %)           
  Presence of comorbidities, n (%)                                                           1625 (38.8 %)        1737 (43.2 %)         \< 0.0001 [2](#FN1599-2){ref-type="table-fn"}
  First colonoscopy, n (%)                                                                   2233 (53.3 %)        2282 (56.7 %)        0.0019 [2](#FN1599-2){ref-type="table-fn"}

SD, standard deviation.

Percentages are referred to the total number of outpatients (n = 3680).

*P*  \< 0.05.

The two groups were homogeneous in terms of demographic variables. However, in Cycle 2, slightly more patients presented comorbidities (43.2 % vs 38.8 %, *P*  \< 0.0001) and were at their first colonoscopy (56.7 % vs 53.3 %, *P*  = 0.0019).

Efficacy of PDSA approach: differences between Cycle 1 and Cycle 2
------------------------------------------------------------------

**Regimen adoption.** Split-dose and same-day regimen adoption significantly increased in Cycle 2 compared to Cycle 1 (55.5 % vs 32.2 % \[ *P*  \< 0.0001\], respectively), while there was a significant reduction in the adoption of a day-before regimen (44.5 % vs 67.8 %; *P*  \< 0.0001). Separate data for split-dose and same-day regimens are provided in [Fig. 1a](#FI1599-1){ref-type="fig"} and [Table 3](#TB1599-3){ref-type="table"} . When colonoscopies were stratified according to scheduled time, in Cycle 2, an improvement in split-dose adoption was achieved in every time slot ( *P*  \< 0.0001 for all), including colonoscopies planned before 0930 ( [Fig. 1b](#FI1599-1){ref-type="fig"} ). However, in Cycle 2, the split-dose regimen became the preferred cleansing regimen only for colonoscopies planned after 1130 ( [Fig. 1 d](#FI1599-1){ref-type="fig"} ), while the day-before regimen remained the preferred solution for colonoscopies planned before 1130 ( [Fig. 1b, c](#FI1599-1){ref-type="fig"} ). The adoption of the same-day regimen significantly increased only for colonoscopies planned after 1400 ( [Fig. 1e](#FI1599-1){ref-type="fig"} ), even if the preferred regimen for afternoon colonoscopies was (in Cycle 1) and confirmed to be (in Cycle 2) the split-dose regimen. The higher rate of split-dose regimen adoption also decreased the preparation-to-colonoscopy time (the so-called "runway time") reducing the proportion of patients for whom this was ≥ 6 hours from 75.3 % of Cycle 1 to 56.4 % of Cycle 2 ( *P*  \< 0.0001; see [Table 3](#TB1599-3){ref-type="table"} and **Supplementary Fig. 2** ).

![ Differences in regimen distribution between Cycle 1 and Cycle 2. **a** General data. Split-dose regimen adoption improved from 29.1 % in Cycle 1 to 51.1 % in Cycle 2 ( *P*  \< 0.0001); same-day regimen adoption increased from 3.1 % to 4.4 % ( *P*  \< 0.0001); day-before regimen adoption decreased from 67.8 % in Cycle 1 to 44.5 % in Cycle 2 ( *P*  = 0.0039). **b** Colonoscopies scheduled before 0930. **c** Colonoscopies scheduled between 0930 and 1130. **d** Colonoscopies scheduled between 1130 and 1400. **e** Colonoscopies scheduled after 1400.](10-1055-a-0996-8118-i1599ei1){#FI1599-1}

###### Differences in bowel cleansing regimen between Cycle 1 and Cycle 2.

  Variable                                                                                            Cycle 1 (n = 4189)   Cycle 2 (n = 4024)   *P* value
  --------------------------------------------------------------------------------------------------- -------------------- -------------------- ------------------------------------------------
  Regimen, n (%)                                                                                                                                 \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Day before                                                                                          2840 (67.8 %)        1790 (44.5 %)        
  Split-dose                                                                                          1221 (29.1 %)        2057 (51.1 %)        
  Same day                                                                                            128 (3.1 %)          177 (4.4 %)          
  Cleansing regimen according to colonoscopy time, n (%)                                                                                        
  Colonoscopy before 0930                                                                                                                        \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Day before                                                                                          952 (89.3 %)         629 (75.9 %)         
  Split-dose                                                                                          110 (10.3 %)         197 (23.8 %)         
  Same day                                                                                            4 (0.4 %)            3 (0.4 %)            
  Colonoscopy 0930 -- 1130                                                                                                                       \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Day before                                                                                          1061 (78.2 %)        689 (53.7 %)         
  Split-dose                                                                                          290 (21.4 %)         584 (45.6 %)         
  Same day                                                                                            6 (0.4 %)            9 (0.7 %)            
  Colonoscopy 1130 -- 1400                                                                                                                       \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Day before                                                                                          456 (56.3 %)         221 (30.7 %)         
  Split-dose                                                                                          328 (40.5 %)         477 (66.2 %)         
  Same day                                                                                            26 (3.2 %)           23 (3.2 %)           
  Colonoscopy after 1400                                                                                                                         \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Day before                                                                                          149 (22.8 %)         49 (7.5 %)           
  Split-dose                                                                                          425 (65.0 %)         479 (73.5 %)         
  Same day                                                                                            80 (12.2 %)          124 (19.0 %)         
  Modality of communication of cleansing regimen, n (%) [2](#FN1599-4){ref-type="table-fn"}                                                     0.193
  Central independent reservation system                                                              1561 (39.6 %)        1486 (39.6 %)        
  Module at endoscopic unit                                                                           872 (22.1 %)         816 (21.8 %)         
  Visit with endoscopic personnel                                                                     536 (13.6 %)         552 (14.7 %)         
  Other written information                                                                           163 (4.1 %)          141 (3.8 %)          
  Other oral information                                                                              293 (7.4 %)          243 (6.5 %)          
  More than one modality                                                                              518 (13.1 %)         510 (13.6 %)         
  Proportion of perceived unclear information (%)                                                                                               
  Central independent reservation system                                                              6.30 %               3.90 %               0.0076 [1](#FN1599-3){ref-type="table-fn"}
  Module at endoscopic unit                                                                           2.60 %               1.70 %               0.0415 [1](#FN1599-3){ref-type="table-fn"}
  Visit with endoscopic personnel                                                                     1.30 %               0.60 %               0.0607
  Other written information                                                                           8.50 %               11.40 %              0.3135
  Other oral information                                                                              13.30 %              13.20 %              0.9737
  Product used for bowel cleansing, n (%)                                                                                                        \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  4 L PEG ± simethicone                                                                               2396 (57.2 %)        2642 (65.7 %)        
  2 L PEG + ascorbate                                                                                 1035 (24.7 %)        923 (22.9 %)         
  Sodium picosulfate / magnesium citrate                                                              370 (8.8 %)          183 (4.5 %)          
  2 L PEG-CS + bisacodyl                                                                              243 (5.8 %)          236 (5.9 %)          
  Sodium phosphate                                                                                    145 (3.5 %)          40 (1.0 %)           
  \% of product consumed, n (%)                                                                                                                 0.0070 [1](#FN1599-3){ref-type="table-fn"}
  100 %                                                                                               3652 (87.2 %)        3585 (89.1 %)        
  75 -- 100 %                                                                                         457 (10.9 %)         356 (8.8 %)          
   \< 75 %                                                                                            80 (1.9 %)           83 (2.1 %)           
  Mean regimen length (SD), hours                                                                     8.60 (6.46)          10.00 (5.84)          \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Mean preparation-to-colonoscopy interval (SD), hours [3](#FN1599-5){ref-type="table-fn"}            10.93 (4.93)         8.55 (4.97)           \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Preparation-to-colonoscopy interval (categorical) [3](#FN1599-5){ref-type="table-fn"}                                                          \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
   \< 3 hours                                                                                         188 (5.1 %)          300 (9.0 %)          
  3 -- 4 hours                                                                                        241 (6.5 %)          387 (11.6 %)         
  4 -- 5 hours                                                                                        270 (7.3 %)          466 (14.0 %)         
  5 -- 6 hours                                                                                        219 (5.9 %)          297 (8.9 %)          
   ≥ 6 hours                                                                                          2793 (75.3 %)        1877 (56.4 %)        
  Means of transport to reach the hospital (outpatients), n (%) [4](#FN1599-6){ref-type="table-fn"}                                              \< 0.0001 [1](#FN1599-3){ref-type="table-fn"}
  Private                                                                                             3427 (93.1 %)        3409 (95.3 %)        
  Public                                                                                              253 (6.9 %)          170 (4.7 %)          
  Patients willing to repeat the same preparation, n (%)                                              3369 (80.4 %)        3342 (83.1 %)        0.0021 [1](#FN1599-3){ref-type="table-fn"}

SD, standard deviation.

*P*  \< 0.05.

Percentages are referred to the total number of patients with available information (n = 3943 for Cycle 1 and 3748 for Cycle 2).

Length and percentages are referred to the total number of patients with available information (n = 3711 for Cycle 1 and 3327 for Cycle 2).

Percentages are referred to the total number of outpatients (n = 3680).

**PDSA-derived local interventions between Cycle 1 and Cycle 2.** According to the PDSA approach, each endoscopy unit was invited to improve its local split-dose adoption rate using information acquired during the educational intervention (through educational meetings and the DVD) and based on the analysis of Cycle 1 data, on the review of published evidence, and on the discussion of hypothetical corrections applicable to single facilities.

[Table 1](#TB1599-1){ref-type="table"} details the improvement process, analyzing the main problems and areas of intervention identified through the ongoing discussion and the main ameliorations self-reported by single centers.

The complete spectrum of patient-, regimen-, and procedure-related variables explored (and compared) in Cycle 1 and 2 are reported in   [Table2](#TB1599-2){ref-type="table"} , [Table 3](#TB1599-3){ref-type="table"} , and [Table 4](#TB1599-4){ref-type="table"} .

###### Colonoscopies: description of preprocedural and intraprocedural variables.

  Variable                                            Cycle 1 (n = 4189)   Cycle 2 (n = 4024)   *P* value
  --------------------------------------------------- -------------------- -------------------- ------------------------------------------------
  First colonoscopy, n (%)                            2233 (53.3 %)        2282 (56.7 %)        0.0019 [1](#FN1599-7){ref-type="table-fn"}
  Indication for colonoscopy, n (%)                                                             0.1692
  Follow-up                                           1214 (29.0 %)        1101 (27.4 %)        
  Screening                                           1056 (25.2 %)        1072 (26.6 %)        
  Symptoms                                            1918 (45.8 %)        1851 (46.0 %)        
  Prescriber, n (%)                                                                             0.0010 [1](#FN1599-7){ref-type="table-fn"}
  GP                                                  1848 (44.1 %)        1669 (41.5 %)        
  Gastroenterologist                                  1332 (31.8 %)        1436 (35.7 %)        
  Other specialist                                    1008 (24.1 %)        919 (22.8 %)         
  Sedation, n (%)                                                                               0.0005 [1](#FN1599-7){ref-type="table-fn"}
  None                                                1304 (31.1 %)        1165 (29.0 %)        
  Conscious                                           2448 (58.5 %)        2511 (62.4 %)        
  Deep                                                436 (10.4 %)         348 (8.6 %)          
  Scheduled colonoscopy time, n (%)                                                             0.0019 [1](#FN1599-7){ref-type="table-fn"}
  Before 0930                                         1066 (27.4 %)        829 (23.8 %)         
  0930 -- 1130                                        1357 (34.9 %)        1282 (36.8 %)        
  1130 -- 1400                                        810 (20.8 %)         721 (20.7 %)         
  After 1400                                          654 (16.8 %)         652 (18.7 %)         
  Cecal intubation, n (%)                             3784 (90.4 %)        3679 (91.4 %)        0.0913
  Right colon cleansing, n (%)                                                                  0.0274 [1](#FN1599-7){ref-type="table-fn"}
  Adequate                                            3224 (77.1 %)        3184 (79.1 %)        
  Not adequate                                        957 (22.9 %)         840 (20.9 %)         
  Left colon cleansing, n (%)                                                                    \< 0.0001 [1](#FN1599-7){ref-type="table-fn"}
  Adequate                                            3645 (87.1 %)        3619 (89.9 %)        
  Not adequate                                        539 (12.9 %)         405 (10.1 %)         
  Endoscopist satisfied with bowel cleansing, n (%)                                             0.0197 [1](#FN1599-7){ref-type="table-fn"}
  Yes                                                 3288 (78.6 %)        3245 (80.6 %)        
  No                                                  897 (21.4 %)         779 (19.4 %)         

*P*  \< 0.05.

Multivariate analyses
---------------------

**Split-dose regimen adoption.** A multivariate logistic regression model was built to evaluate the variables associated with the adoption of a split-dose regimen (see [Table 5](#TB1599-5){ref-type="table"} ). A colonoscopy scheduled before 0930 significantly reduced the probability of a split-dose regimen being prescribed, while there was an almost 3-fold and more than 7-fold increase in the probability when colonoscopy was planned between 0930 and 1130 (OR = 2.6 \[CI 2.3 -- 3.1\]) and between 1130 and 1400 (OR = 7 \[CI 5.9 -- 8.4\]), respectively. Considering as reference those patients receiving the cleansing regimen by the independent central reservation system, the information being provided by the endoscopy unit through a module and, even more, through a visit with endoscopy personnel significantly increased the probability of adopting a split-dose regimen (OR = 1.6 \[CI 1.3 -- 1.9\] for the module and OR = 2.1 \[CI 1.7 -- 2.5\] for the visit), as well as the information being provided through more than one modality (OR = 2.8 \[CI 2.3 -- 3.3\]). A split-dose regimen was less likely to be adopted when colonoscopy was planned under deep sedation (OR = 0.5 vs no sedation, CI 0.4 -- 0.6), and when the patient had a higher education level (secondary vs primary: OR = 0.8 \[CI 0.6 -- 0.9\] and degree vs primary: OR = 0.8 \[CI 0.7 -- 0.99\]), while it was more probable if colonoscopy was the first (OR = 1.3 \[CI 1.1 -- 1.5\]), was prescribed by a gastroenterologist rather than a general practitioner (OR = 1.3 \[CI 1.1 -- 1.5\]), and for screening rather than for surveillance (OR = 1.3 \[CI 1.1 -- 1.5\]). No influence of sex, comorbidities, or inpatient vs outpatient status was found. Being enrolled in Cycle 2 was an independent variable associated with an almost 3-fold increased probability of split-dose regimen adoption (OR = 2.9; CI 2.6 -- 3.3).

###### Multivariate logistic regression model: predictors of the adoption of a split-dose versus a day-before regimen. Results are expressed as odds ratio (OR) and 95 % confidence interval (CI). For this model, afternoon colonoscopies were excluded and 5994 observations were used.

  Variable                                 Odds Ratio   95 % Confidence interval   *P* value
  ---------------------------------------- ------------ -------------------------- ------------
  Cycle 1                                  1                                        \< 0.0001
  Cycle 2                                  2.923        2.583 -- 3.311             
  Scheduled time for colonoscopy                                                    \< 0.0001
  Before 0930                              1                                       
  0930 -- 1130                             2.637        2.259 -- 3.080             
  1130 -- 1400                             7.036        5.924 -- 8.357             
  Communication of bowel cleansing                                                  \< 0.0001
  Independent reservation system           1                                       
  Form from the Endoscopy unit             1.57         1.323 -- 1.863             
  Visit with Endoscopy personnel           2.087        1.715 -- 2.540             
  Other written information                0.481        0.329 -- 0.702             
  Other oral information                   1.284        0.987 -- 1.670             
  More than one modality                   2.752        2.290 -- 3.308             
  Missing information                      0.512        0.289 -- 0.908             
  Sedation                                                                          \< 0.0001
  None                                     1                                       
  Conscious                                0.985        0.858 -- 1.131             
  Deep                                     0.5          0.391 -- 0.640             
  First colonoscopy                        1.281        1.115 -- 1.472              \< 0.0001
  Prescriber of the colonoscopy                                                    0.0001
  General practitioner                     1                                       
  Gastroenterologist                       1.314        1.136 -- 1.519             
  Other specialist                         0.913        0.774 -- 1.076             
  Product used for bowel cleansing                                                 0.0005
  4 L PEG ± simethicone                    1                                       
  2 L PEG + ascorbate                      1.025        0.881 -- 1.193             
  2 L PEG + citrate + bisacodyl            0.55         0.408 -- 0.741             
  Magnesium citrate + sodium picosulfate   0.896        0.697 -- 1.152             
  Sodium phosphate                         1.218        0.820 -- 1.810             
  Education                                                                        0.006
  Primary                                  1                                       
  Secondary I                              0.958        0.804 -- 1.141             
  Secondary II                             0.761        0.642 -- 0.902             
  Degree or above                          0.803        0.655 -- 0.986             
  Indication for colonoscopy                                                       0.0091
  Surveillance                             1                                       
  Screening                                1.255        1.047 -- 1.504             
  Symptoms                                 1.013        0.859 -- 1.195             

**Other multivariate models.** Other multivariate logistic regression models (dependent variables: adoption of a split-dose or a same-day regimen for afternoon colonoscopies; patients' willingness to repeat the preparation; endoscopist satisfaction about bowel cleansing; adequate preparation of left and right colon) are described in **Supplementary Tables 1, 2, 3, 4, and 5** . A split-dose regimen was an independent predictor of cleansing adequacy, endoscopist satisfaction, and patient willingness to repeat the regimen.

Discussion
==========

According to our study, including 8213 patients, a nationwide implementation of the PDSA approach was able to almost double the rate of split-dose regimen adoption. In addition, such an approach significantly decreased the "runway time", a known strong predictor of better bowel preparation [@JR1599-19] . Of note, most of the interventions applied between the two cycles were simple organizational changes, not requiring any technological or economic effort.

We believe that the results of our study are relevant for the following reasons.

First of all, despite the split-dose regimen being recommended by different guidelines [@JR1599-5] [@JR1599-6] , being associated with better bowel cleansing [@JR1599-1] [@JR1599-2] , and yielding a higher detection of colonic lesions [@JR1599-3] [@JR1599-4] , the current adoption of this regimen is still disappointing. For instance, in our study, almost 70 % of colonoscopies were not prepared using a split-dose regimen during Cycle 1.

Second, we demonstrated that a simple auditing of bowel cleansing in two phases separated by an educational intervention was sufficient to stimulate spontaneous local interventions determining a significant increase in split-dose regimen adoption. This was not unexpected as the PDSA approach has already proven its efficacy in other areas of bowel cleansing improvement [@JR1599-13] [@JR1599-14] [@JR1599-18] . Of note, the PDSA approach has no direct costs related to the model itself. The indirect costs linked to the eventual diffusion of educational material or to the time spent in the process are not expected to represent a significant burden in an era in which hospital administrations actively sustain actions involved in quality improvement.

Third, we found that such an improvement was mainly obtained through local organizational skills. Colonoscopies scheduled after 0930 and a more careful use of deep sedation significantly increased the probability of split-dose regimen adoption. These factors suggest that it could be simpler for endoscopy facilities to take care of these center-related factors, instead of promoting resource-consuming interventions such as the development of booklets or mobile phone applications, the use of short message services (SMS), or hiring navigators [@JR1599-13] [@JR1599-20] [@JR1599-21] [@JR1599-22] .

Fourth, despite the PDSA-driven implementation, at the end of our study, more than 40 % of colonoscopies were still being prepared through the day-before regimen. In this scenario, analyses of barriers opposing adherence to a split-dose regimen are relevant, particularly in the setting of morning colonoscopies, for which this modality is recommended and its adoption most challenging. In our study, to our knowledge the largest analyzing this outcome, early morning colonoscopies, deep sedation, and a higher patient educational level were negatively associated with split-dose regimen adoption, whereas the regimen being communicated by the endoscopy unit, the colonoscopy being the first one, being prescribed for screening and by a gastroenterologist were all associated with a higher probability of split-dose regimen adoption. This adds to previous experiences analyzing barriers against a split-dose regimen [@JR1599-10] [@JR1599-11] .

As a consequence, some areas of intervention may be deduced. The role of patient-related factors must not be underestimated: the fact that, in our study, a higher educational level was associated with a reduced probability of split adoption could probably suggest that these patients are less prone to passively receive instructions, may feel more at liberty to deviate from protocols, may be looking for a second opinion (e. g. pharmacist, previous users, general practitioner), or for additional information (e. g. internet), and this could represent a barrier when this claim for involvement meets low-quality information, as already demonstrated [@JR1599-11] , especially in a period of changing practices. However, it can be reasonably assumed that a higher cultural level could eventually represent fertile ground for educational interventions, if the advantages of a split dose regimen are adequately and exhaustively explained. In any case, our data indicate that organizational factors are likely to play a pivotal and major role in overcoming other individual barriers. For example, even if an amelioration in split-dose regimen adoption was also achieved for colonoscopies before 0930, preferring to schedule upper endoscopies or recto-sigmoidoscopies in early morning slots could represent a significant intervention to optimize bowel cleansing. However, it is not just endoscopists who have a role in this improvement. For example, even though studies have demonstrated that residual gastric volume is not higher with a split-dose regimen when the last dose of preparation is consumed at least 3 hours before the colonoscopy [@JR1599-23] [@JR1599-24] [@JR1599-25] [@JR1599-26] , in our study, anesthesiological concerns seem to be relevant in hampering the adoption of a split-dose regimen.

Our study has several limitations. First, patients in Cycle 1 and Cycle 2 were not matched; however, no demographical differences were observed between the two groups apart from the slightly higher prevalence of comorbidities in Cycle 2. This is reassuring as it did not affect the possibility to improve split-dose regimen adoption. Second, we did not survey the rate of bowel movements or the need for travel interruption while reaching the endoscopy unit, but the higher prevalence of patients willing to repeat the same preparation in Cycle 2 (with split-dose regimen predicting this willingness in multivariate analyses) lowers the suspicion of split-dose-related unpleasant events. Third, we detected only a slight improvement in bowel cleansing adequacy after the intervention; however, since this was not the primary outcome, it was subjectively and unblindely evaluated as "adequate" or "not adequate" without the use of a validated scale and without investigating potentially relevant confounding factors (e. g. drugs such as antidepressants or opioids, comorbidity scores, previous bowel regularity, etc.), and therefore, the multivariate analysis of **Supplementary Tables 4 and 5** must take into account these concerns; however, the efficacy of split-dose regimens in improving major outcomes (i. e. bowel cleansing, right colon cleansing, polyp, adenoma, and advanced adenoma detection rates, etc.) has been extensively and firmly demonstrated [@JR1599-1] [@JR1599-2] [@JR1599-3] [@JR1599-4] , and therefore, the low magnitude of bowel cleansing improvement in this study must be attributed exclusively to the non-standardized method we used to measure this outcome. Fourth, iteration of intermediate short cycles exploring single interventions is theoretically missing in our study as well as in the majority of published studies using a PDSA approach [@JR1599-17] ; however, we tried to compensate for this by conducting a multivariate analysis deducing the main factors driving the changes in split-dose regimen adoption, most likely reflecting those to focus on during future clinical practice or research. Finally, interventions between the two cycles were not preordered or fixed, but such a flexible approach was nevertheless successful, further reassuring us about the generalizability of the method, which lends itself well to the variability of the volumes, setting, and expertise of different local facilities. Of note, the participating centers included both academic and non-academic centers, and even a small proportion of private facilities.

Despite all these limitations, to our knowledge, this is the largest study targeting an improvement in split-dose regimen adoption, the first to use the PDSA approach with this aim, and the only study addressing this goal on an unselected population (regardless of age, comorbidities, indication for colonoscopy, inpatient versus outpatient status, etc.). Although the study was not meant to evaluate the efficacy of specific interventions, we have highlighted a number of factors significantly favoring or limiting split-dose regimen adoption, potentially steering further research on this topic. A PDSA approach, through awareness of the problem, attention to quality improvement, and creation of feedback, has led to a doubling of split-dose regimen adoption in the participating centers.

Participating centers
=====================

Coordinating Centre: Endoscopy Unit, Sant'Andrea Hospital, Faculty of Medicine and Psychology, Sapienza, University of Rome. For the complete list of participating centers, please see **Supplementary Material** , Statement 3.
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